{"status":"ok","message-type":"event-list","message":{"next-cursor":"75919e0b-4839-48e5-b095-15c97c327254","total-results":3,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1016\/s0304-4017(00)00223-5","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-02-08T00:00:00Z","subj_id":"https:\/\/lens.org\/102-372-639-602-797","id":"f9aa4806-859e-0e61-7c1e-f53005bb2cba","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Recombinant Vectors Based On The Modified Vaccinia Ankara (Mva) Virus As Vaccines Against Leishmaniasis","pid":"https:\/\/lens.org\/102-372-639-602-797","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T00:58:02Z","relation_type_id":"cites"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1016\/S0304-4017(00)00223-5","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2013-04-05T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1371\/journal.pone.0060535","id":"8a040a10-80e3-450e-a7fa-0153590316e4","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-07-12T19:34:44Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1016\/S0304-4017(00)00223-5","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2012-04-25T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1371\/journal.pone.0035349","id":"75919e0b-4839-48e5-b095-15c97c327254","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-08-03T03:17:28Z","relation_type_id":"references"}]}}